Related Experiment Video
Updated: Jun 13, 2026
11:47
A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
Genetics of osteoporosis
Stuart H Ralston1, André G Uitterlinden
1Rheumatic Diseases Unit, Molecular Medicine Centre, University of Edinburgh, Western General Hospital, Edinburgh EH4 2XU, United Kingdom. stuart.ralston@ed.ac.uk
Endocrine Reviews
|May 1, 2010
Summary
Osteoporosis susceptibility is strongly genetic, influenced by bone mineral density and fracture risk. While many genes are identified, most genetic factors regulating bone health remain undiscovered.
Area of Science:
- Genetics
- Bone Biology
- Osteoporosis Research
Background:
- Osteoporosis is a prevalent condition marked by low bone mass and microarchitectural defects, leading to increased fracture risk.
- Bone mineral density (BMD) and other fracture determinants exhibit high heritability, as evidenced by twin and family studies.
- Genetic factors interact with environmental influences like diet and exercise to determine osteoporosis susceptibility.
Purpose of the Study:
- To review the progress in identifying genetic factors contributing to bone mineral density (BMD) and fracture risk.
- To highlight the methodologies used in discovering genes associated with bone metabolism.
- To underscore the ongoing need for further genetic research in osteoporosis.
Main Methods:
- Analysis of rare Mendelian bone diseases with major bone mass abnormalities to identify large-effect genes.
- Genome-wide association studies (GWAS) to detect common genetic variants with small effect sizes influencing BMD and fracture risk.
- Integration of findings from genetic studies to understand the regulation of bone metabolism.
Main Results:
- Identification of numerous genes and loci regulating BMD, some previously unsuspected in bone metabolism.
- Discovery of both large-effect variants in rare diseases and small-effect variants in the general population.
- Significant advancements in understanding the genetic architecture of osteoporosis over the past 15 years.
Conclusions:
- Substantial progress has been made in identifying genes linked to BMD and fracture risk.
- The majority of genetic variants influencing these osteoporosis-related phenotypes are yet to be discovered.
- Continued genetic research is crucial for a comprehensive understanding and potential treatment of osteoporosis.
Related Concept Videos
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:17Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
01:40Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
01:31Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...